October 21, 2014 /

Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne (October 2014)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy


Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne (October 2014)

Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne: Results of the phase 3 double-blind, randomized, placebo-controlled DELOS trial. Santhera Pharmaceuticals presented data of the Phase III DELOS trial during a webinar hosted by Parent Project Muscular Dystrophy on Wednesday, October 15th.

Research & Clinical Trial Webinars, Webinars
Posted on October 21, 2014
LinkedinPin ItWhatsApp

Join Our Mailing List